Table 1.
Variable | Count (%) or mean (range) |
---|---|
Male | 313 (45%) |
Age, years | 86 (80–99) |
Race | |
White | 578 (83%) |
Black | 45 (7%) |
Asian | 22 (3%) |
Other/Unknown | 50 (7%) |
PMH | |
Neuro | 328 (47%) |
Dementia | 165 (24%) |
Prior TBI | 32 (5%) |
CHF | 104 (15%) |
CAD | 196 (28%) |
COPD | 71 (10%) |
ESRD | 17 (2%) |
Cirrhosis | 3 (0.4%) |
Diabetes | 196 (28%) |
Substance abuse | 14 (2%) |
Anticoagulant use | 163 (24%) |
Antiplatelet use | 377 (54%) |
Mechanism of injury | |
Found down | 41 (6%) |
Fall >10ft | 12 (2%) |
Fall <10ft | 592 (85%) |
MVC | 23 (3%) |
Other/Unknown | 27 (4%) |
GCS | |
3–8 | 76 (11%) |
9–12 | 56 (8%) |
13–15 | 563 (81%) |
ISS | 17 (1–38) |
Pupillary reactivity | |
Both reactive | 636 (92%) |
None reactive | 38 (6%) |
One reactive | 21 (3%) |
Subdural hematoma | |
Acute | 660 (95%) |
Subacute | 21 (3%) |
Chronic | 12 (2%) |
Epidural hematoma | 13 (2%) |
IVH | 38 (6%) |
SAH | 215 (31%) |
Contusion | 84 (12%) |
DAI | 1 (0.1%) |
Skull fracture | 48 (7%) |
Abbreviations: PMH - past medical history; TBI - traumatic brain injury; CHF - congestive heart failure; CAD - coronary artery disease; COPD - chronic obstructive pulmonary disease; ESRD - end-stage renal disease; GCS - Glasgow coma scale; ISS - injury severity scale; IVH - intraventricular hemorrhage; SAH - subarachnoid hemorrhage; DAI - diffuse axonal injury